Menu
Log in
Log in

News

Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma

04 Jun 2024 3:34 PM | ISDE Membership (Administrator)

Sarah C. McKay, BS; Brian E. Louie, MD; Daniela Molena, MD; Weston G. Andrews, MD; Thomas Boerner, MD; Wayne L. Hofstetter, MD; Jonathan Yeung, MD; Gail E. Darling, MD; Ahmed Sharata, MD; Christian G. Peyre, MD; Colin Dunn, MD; John C. Lipham, MD; Horia Marginean, MD; Steven R. DeMeester, MD

Read Abstract: Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software